What is Immunovant, Inc.'s AOCI?

Immunovant, Inc. (IMVT) reported AOCI of $730K in Q1 2026.

How has Immunovant, Inc.'s AOCI changed year-over-year?

Immunovant, Inc.'s AOCI decreased by 50.0% year-over-year, from $1.46M to $730K.

What is the long-term trend for Immunovant, Inc.'s AOCI?

Over 5 years (2021 to 2026), Immunovant, Inc.'s AOCI has grown at a 19.6% compound annual growth rate (CAGR), from -$298K to $730K.

Accumulated gains and losses bypassing the income statement — unrealized investment gains/losses, currency translation, pension adjustments, and hedge results.

Immunovant, Inc. IMVT AOCI

AOCI at other companies

Johnson & JohnsonJNJ

-$14.83B-26.3%

ImmunityBio, Inc.IBRX

$27.45M+37.6%

Summit TherapeuticsSMMT

-$2.63M-2.7%

Roivant SciencesROIV

$4.36M-53.8%

Apogee Therapeutics, Inc.APGE

——

Protagonist TherapeuticsPTGX

——

Other financials

Income statement

See full

Net income-$147.9M-38.9%

EPS (diluted)-$0.73-15.9%

Balance sheet

See full

Cash & equivalents$902.1M+26.4%

Total debt$72.0K-26.5%

Total equity$852.6M+20.5%

Total assets$957.0M+23.3%

Cash flow

See full

Operating cash flow-$95.1M+14.1%

CapEx$8.0K-96.0%

Free cash flow-$95.1M+14.2%

Valuation

See full

Market cap$7.26B+74.2%

Enterprise value$6.35B+89.7%

Returns & leverage

See full

Return on equity-64.8%+2.5pp

Debt / equity0×0.0×

Current ratio9.1×-2.1×

Where this comes from

Reported directly by Immunovant, Inc. in its filing.

Tagged under the XBRL concept us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax.

The official record: Immunovant, Inc.’s 10-K, filed May 20, 2026, on SEC EDGAR. View the filing →

Ask your AI about Immunovant, Inc.'s aoci.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Immunovant, Inc.'s AOCI?: Immunovant, Inc. (IMVT) reported AOCI of $730K in Q1 2026.
How has Immunovant, Inc.'s AOCI changed year-over-year?: Immunovant, Inc.'s AOCI decreased by 50.0% year-over-year, from $1.46M to $730K.
What is the long-term trend for Immunovant, Inc.'s AOCI?: Over 5 years (2021 to 2026), Immunovant, Inc.'s AOCI has grown at a 19.6% compound annual growth rate (CAGR), from -$298K to $730K.
What does AOCI mean?: Accumulated gains and losses bypassing the income statement — unrealized investment gains/losses, currency translation, pension adjustments, and hedge results.